Shilpa Medicare Ltd.

SHILPAMED

₹721.8

5.95% (40.55)

Market Cap

₹7,065 Cr.

P/E

80.02

About

Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Presently, th… Read more

Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at R… Read more

Low

418

52W Range

High

960

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

8 Yes

Positive for this company

0 Neutral

Neutral for this company

9 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Promoter Holding

Promoters has been selling shares in the open market over last 90 days

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Asset turnover is responsible for roe increase over last 10 years
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Debt

Company might have issues servicing its debt
Share price

Share price has increased over last 10 years but more due to rerating
Working Capital

Company has significant working capital which is dragging its roce and roe
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Product Wise Break-Up - Pharmaceutical product and services

Product Wise Break-Up - API Business

Location Wise Break-Up - Formulation Business

Operational Metrics

US DMF Filings (.)
Source
Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Approved By USFDA (.)
Source
Number of ANDA's Filed in Europe
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Shilpa Medicare Ltd. Business

What does Shilpa Medicare do?

Shilpa Medicare Limited, a global pharmaceutical company based in India, specializes in manufacturing affordable APIs and formulations since 1987, supplying to various regulated markets worldwide.

Who are the competitors of Shilpa Medicare?

Shilpa Medicare major competitors are Aarti Pharmalabs, Supriya Lifescience, AMI Organics, Aarti Drugs, Morepen Laboratories, Solara Active Pharma, IOL Chem & Pharma.
Market Cap of Shilpa Medicare is ₹6,656 Crs.
While the median market cap of its peers are ₹3,331 Crs.

Is Shilpa Medicare financially stable compared to its competitors?

Shilpa Medicare seems to be less financially stable compared to its competitors.
Altman Z score of Shilpa Medicare is 4.52 and is ranked 5 out of its 8 competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Superstar Favourites

Companies where superstar investors like Rakesh Jhunjhunwala, Asish Kacholia have invested

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation		Mar Jun Sep Dec	Mar Jun Sep Dec	Feb Mar Jun Aug Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Dec
Conference Call		Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Shilpa Medicare Ltd.

View the discussion on ValuePickr

Deep Dive Into Shilpa Medicare - Numbers and Narratives

Shilpa Medicare - DISCUSSION DOCUMENT – TIA CONFERENCE FEB 2024 - Tushar Bohra

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Shilpa Medicare Ltd.